Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17047484 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine

Study has passed its completion date and status has not been verified in more than two years.